Navigation Links
Pancreatic Cancer Biomarkers Found
Date:6/13/2008

Blood test for 5 proteins could detect disease sooner, when it's more treatable

FRIDAY, June 13 (HealthDay News) -- Five proteins linked to early development of pancreatic cancer have been identified by U.S. researchers, who said the finding is a step forward in efforts to develop a blood test to detect this type of cancer in the early stages, when cure rates are highest.

"Our team identified, for the first time, protein changes associated with early-stage pancreatic tumor development in genetically engineered mice that were also found to be associated with the presence of disease in humans at an early, pre-symptomatic stage," senior author Dr. Samir Hanash, of the Fred Hutchinson Cancer Research Center in Seattle, said in a prepared statement.

They first identified the five proteins in mice with a precancerous condition called pancreatic intraepithelial neoplasma. The condition, if left untreated, eventually progresses to full-blown pancreatic cancer. The researchers then looked for the same proteins in blood samples from 13 people with asymptomatic, early-stage pancreatic cancer.

The study was published in this week's issue of the online journal PLoS Medicine.

If this five-biomarker panel can be developed into a commercial screening test, it may prove particularly useful when combined with a currently available test that measures levels of a pancreatic cancer biomarker called CA19.9. Eighty percent of newly diagnosed pancreatic cancer patients have elevated levels of CA19.9, which is not linked to early-stage disease with symptoms.

The researchers suggested that combined use of the five-biomarker panel and the CA19.9 test may greatly improve detection of early-stage pancreatic cancer before the onset of symptoms and may also help distinguish between cancer and pancreatitis, a noncancerous, inflammatory condition.

Pancreatic cancer is the fourth leading cause of cancer death in the United States. It has a five-year survival rate of only 3 percent. Because there are no symptoms in the early stages, most patients aren't diagnosed until the cancer has spread beyond the pancreas. This is a major reason for the poor long-term survival rates.

More information

The American Cancer Society has more about pancreatic cancer.



-- Robert Preidt



SOURCE: Fred Hutchinson Cancer Research Center, news release, June 9, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New treatment combination safe for pancreatic cancer patients
2. 3-Drug Combo Improves Advanced Pancreatic Cancer Outcomes
3. Beer Drinking May Speed Pancreatic Cancer Onset
4. Traditional herbal medicine kills pancreatic cancer cells, Jefferson researchers report
5. The Pancreatic Cancer Action Network Announces Its 2008 Research Grant Awards Totaling Over $1 Million in New Research Funding
6. Calorie restricted diet prevents pancreatic inflammation and cancer
7. Blood pressure drugs halt pancreatic cancer cell growth, Jefferson researchers find
8. Jefferson scientists discovery may help explain smoking-pancreatic cancer link
9. Karmanos Researchers Report Enhanced Chemosensitivity of Pancreatic Cancer Cells by Black Seed Component
10. Patrick Swayzes Diagnosis With Pancreatic Cancer: a Statement From the Pancreatic Cancer Action Network
11. Treatment Combo for Pancreatic Cancer Has Limited Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards luncheon ... editorial and design excellence across a range of sectors. This year’s program included the ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... South Korea , Oct. 4, 2017  South ... its next-generation CPR training aide "cprCUBE" on Kickstarter. The ... chest compression during cardiac arrests with better efficiency compared ... It also offers real-time feedback on efficacy of the ... The crowdfunding campaign has a goal to raise $5,000. ...
(Date:10/2/2017)... ORLANDO, Fla. , Oct. 2, 2017  AllianceRx ... services company formed by Walgreens and pharmacy benefit manager ... of its new brand, which included the unveiling of ... Fla. , as well as at a few ... introduces the new brand to patients, some of whom ...
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
Breaking Medicine Technology: